VAERS reports by lot

Moderna COVID-19 lot 008B212A: VAERS reports

151 VAERS reports list lot 008B212A as a Moderna COVID-19 vaccine, received between 2021-03-18 and 2023-08-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
151
Reports
16%
Marked serious
8
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)12521%
Neurological9216%
Gastrointestinal8114%
Cardiac / Cardiovascular6812%
Injection-site / Local reaction5710%
Musculoskeletal498%
Respiratory386%
Dermatological (non-injection-site)346%
Allergic / Anaphylactic183%
Psychiatric / Neuropsychiatric132%
Thrombotic / Hematological81%
Autoimmune / Immune-mediated20%
Reproductive / Menstrual20%

Where reports came from

U.S. state of the reporter, where given (top 12).

Kentucky24
New York16
Texas12
Michigan12
Pennsylvania11
California10
North Carolina10
Colorado7
South Dakota6
South Carolina5
Virginia3
Iowa2

Reports by month received

2021-0323
2021-0437
2021-059
2021-065
2021-074
2021-0829
2021-095
2021-1010
2021-113
2021-129
2022-0110
2022-024
2022-031
2022-051
2023-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.